189 related articles for article (PubMed ID: 2918461)
1. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.
Aboulafia D; Miles SA; Saks SR; Mitsuyasu RT
J Acquir Immune Defic Syndr (1988); 1989; 2(1):54-8. PubMed ID: 2918461
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
3. Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trial.
Kahn JO; Kaplan LD; Volberding PA; Ziegler JL; Crowe S; Saks SR; Abrams DI
J Acquir Immune Defic Syndr (1988); 1989; 2(3):217-23. PubMed ID: 2498507
[TBL] [Abstract][Full Text] [Related]
4. Clinical aspects of AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Curr Opin Oncol; 1993 Sep; 5(5):835-44. PubMed ID: 8218496
[TBL] [Abstract][Full Text] [Related]
5. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma.
Pluda JM; Shay LE; Foli A; Tannenbaum S; Cohen PJ; Goldspiel BR; Adamo D; Cooper MR; Broder S; Yarchoan R
J Natl Cancer Inst; 1993 Oct; 85(19):1585-92. PubMed ID: 7692072
[TBL] [Abstract][Full Text] [Related]
6. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
[TBL] [Abstract][Full Text] [Related]
8. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
[TBL] [Abstract][Full Text] [Related]
9. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
[TBL] [Abstract][Full Text] [Related]
10. AIDS-associated Kaposi's sarcoma pathogenesis, clinical features, and treatment.
Masood R; Cai J; Law R; Gill P
Curr Opin Oncol; 1993 Sep; 5(5):831-4. PubMed ID: 8218495
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Evans LM; Itri LM; Campion M; Wyler-Plaut R; Krown SE; Groopman JE; Goldsweig H; Volberding PA; West SB; Mitsuyasu RT
J Immunother (1991); 1991 Feb; 10(1):39-50. PubMed ID: 1826454
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
[TBL] [Abstract][Full Text] [Related]
13. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome.
Groopman JE; Gottlieb MS; Goodman J; Mitsuyasu RT; Conant MA; Prince H; Fahey JL; Derezin M; Weinstein WM; Casavante C
Ann Intern Med; 1984 May; 100(5):671-6. PubMed ID: 6712031
[TBL] [Abstract][Full Text] [Related]
14. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.
Saiag P; Pavlovic M; Clerici T; Feauveau V; Nicolas JC; Emile D; Chastang C
AIDS; 1998 Nov; 12(16):2169-76. PubMed ID: 9833858
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma.
Friedman-Kien AE; Saltzman BR
J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1237-50. PubMed ID: 2193952
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
18. Aetiology of Kaposi's sarcoma: current understanding and implications for therapy.
Boshoff C; Weiss RA
Mol Med Today; 1997 Nov; 3(11):488-94. PubMed ID: 9430784
[TBL] [Abstract][Full Text] [Related]
19. Therapy of epidemic Kaposi's sarcoma.
Groopman JE
Semin Hematol; 1986 Jul; 23(3 Suppl 1):14-9. PubMed ID: 3090689
[TBL] [Abstract][Full Text] [Related]
20. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
